Lymph Node Mapping Via Flourescent Dye in Colon Cancer
Launched by UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF · Jul 10, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to better identify lymph nodes that are affected by colon cancer. Lymph nodes are small glands that help fight infection and can sometimes be sites where cancer spreads. The researchers want to see if these lymph nodes, which drain fluid from the area around the cancer, are only found within the area that doctors usually remove during surgery or if some are located outside of that area. To help visualize these nodes, they will use a special dye called indocyanine green, which makes the nodes glow under specific lighting.
To participate in this trial, you need to have a specific type of colon cancer called adenocarcinoma that is diagnosed through a biopsy. Those who are not interested in joining, have a different type of cancer, or cannot have the necessary marking done through an endoscopy will not be eligible. If you qualify and decide to participate, you will help researchers learn more about the best ways to manage colon cancer and possibly improve surgical outcomes for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • histologically diagnosed carcinoma of the ascending, transverse, descending or sigmoid colon.
- Exclusion Criteria:
- • not wanting to participate
- • other carcinoma then adenocarcinoma
- • endoscopic marking not possible
About Universitätsklinikum Hamburg Eppendorf
Universitätsklinikum Hamburg-Eppendorf (UKE) is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, UKE integrates state-of-the-art facilities with a multidisciplinary approach, fostering collaboration among top-tier researchers, clinicians, and healthcare professionals. The institution is dedicated to improving patient outcomes by conducting rigorous scientific investigations that address critical health challenges, ultimately contributing to the development of novel therapies and enhancing medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hamburg, , Germany
Patients applied
Trial Officials
Daniel Perez, Prof. Dr.
Principal Investigator
Dept of General Visceral and Thoracic Surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials